RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy
1 clinical trials · Condition
◉ Watch RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy
| Record | Firm | Date |
|---|---|---|
| Crizanlizumab for Treatment of Retinal Vasculopathy With Cerebral Leukoencephalopathy (RVCL) (NCT04611880) | Washington University School of Medicine | 2021-01-25 |
Track RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy automatically
Every clearance here is in the API, with alerts when new ones post.